ACAD Return on Tangible Equity | ACADIA PHARMACEUTICALS INC.

ACADIA PHARMACEUTICALS INC. (ACAD) Return on Tangible Equity

2026-06-30: Return Tang Equity 31.62%.
2026-03-31: Return Tang Equity 32.90%.
2025-12-31: Return Tang Equity 34.96%.
2025-09-30: Return Tang Equity 32.42%.

Complete source-backed return tang equity history.

Available history: 2009-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	31.62%
2026-03-31	32.90%
2025-12-31	34.96%
2025-09-30	32.42%
2025-06-30	31.38%
2025-03-31	35.31%
2024-12-31	36.94%
2024-09-30	27.25%
2024-06-30	7.48%
2024-03-31	-0.48%
2023-12-31	-16.73%
2023-09-30	-50.39%
2023-06-30	-33.83%
2023-03-31	-47.90%
2022-12-31	-53.94%
2022-09-30	-52.04%
2022-06-30	-47.94%
2022-03-31	-49.10%
2021-12-31	-31.50%
2021-09-30	-34.27%
2021-06-30	-47.00%
2021-03-31	-45.33%
2020-12-31	-45.49%
2020-09-30	-41.41%
2020-06-30	-34.38%
2020-03-31	-37.75%
2019-12-31	-34.04%
2019-09-30	-36.36%
2019-06-30	-70.32%
2019-03-31	-67.31%
2018-12-31	-52.05%
2018-09-30	-115.38%
2018-06-30	-98.04%
2018-03-31	-86.39%
2017-12-31	-88.43%
2017-09-30	-81.02%
2017-06-30	-75.06%
2017-03-31	-68.84%
2016-12-31	-53.17%
2016-09-30	-41.83%
2016-06-30	-51.34%
2016-03-31	-39.04%
2015-12-31	-82.32%
2015-09-30	-64.67%
2015-06-30	-51.95%
2015-03-31	-40.35%
2014-12-31	-29.88%
2014-09-30	-23.04%
2014-06-30	-17.73%
2014-03-31	-13.59%
2013-12-31	-20.84%
2013-09-30	-18.10%
2013-06-30	-13.45%
2013-03-31	-26.05%
2012-12-31	-24.53%
2012-09-30	-109.48%
2012-06-30	-173.22%
2012-03-31	-131.65%
2011-12-31	-97.44%
2011-09-30	41.49%
2011-06-30	38.16%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	34.96%
2024-12-31	36.94%
2023-12-31	-16.73%
2022-12-31	-53.94%
2021-12-31	-31.50%
2020-12-31	-45.49%
2019-12-31	-34.04%
2018-12-31	-52.05%
2017-12-31	-88.43%
2016-12-31	-53.17%
2015-12-31	-82.32%
2014-12-31	-29.88%
2013-12-31	-20.84%
2012-12-31	-24.53%
2011-12-31	-97.44%
2010-12-31	50.99%
2009-12-31	-372.67%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
AbCellera Biologics Inc. (ABCL)		$3.879B	-14.59
Xenon Pharmaceuticals Inc. (XENE)		$3.684B	-14.27
Organon & Co. (OGN)	United States	$3.603B	17.03
IDEAYA Biosciences, Inc. (IDYA)	United States	$3.540B	-20.52
Tango Therapeutics, Inc. (TNGX)	United States	$4.154B	-42.53
Indivior Pharmaceuticals, Inc. (INDV)		$4.250B	14.09
Amylyx Pharmaceuticals, Inc. (AMLX)	United States	$3.361B	-13.15
Viking Therapeutics, Inc. (VKTX)	United States	$4.287B	-8.51
Enliven Therapeutics, Inc. (ELVN)	United States	$3.307B	-35.07
Arcutis Biotherapeutics, Inc. (ARQT)	United States	$3.303B	115.47